Challenges in Molecular Testing
Patient biopsies can be difficult to acquire and the resultant sample limited. Nevertheless, multiple clinical relevant variants have to be analysed within a short time to be able to make an informed treatment decision.
Selecting a molecular test doesn’t always have to mean a compromise between sensitivity, costs and turnaround time.
The MassARRAY Dx System is a CE-IVD marked benchtop mass spectrometer that provides timely and accurate multiplexed analysis of up to hundreds of clinically relevant mutations in a single workflow.
SINGLE DAY TURNAROUND
DNA to data in a single workday with minimal DNA required
COMPATIBLE ACROSS SAMPLE TYPES
Blood, serum, buccal cells, micro-dissected & fresh frozen tumor cells, heterogenous solid tumor samples, fine needle aspirates, circulating free and tumor DNA from plasma (liquid biopsy)
The flexible throughput capacity can meet the needs of any testing volume. The system works with standard 96 well plates.
The technology is well proven for the accurate and reproducible results illustrated in over 4,000 publications.
LOW COST PER SAMPLE
Multiplexed analysis reduces per sample cost, targeted content eliminates bioinformatic burden, and scalable throughput optimizes batch and resource requirements.
The system supports diverse applications, allowing labs to consolidate tests onto a single platform.